Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chollet

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 8, 2006
A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993)R E Coleman, L Biganzoli, P Canney, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2004
Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck. An EORTC New Drug Development Group studyF Duffaud, M Borner, P Chollet, et al.
Breast (Edinburgh, Scotland)|October 19, 2005
Neoadjuvant endocrine therapy in breast cancerC Abrial, M-A Mouret-Reynier, H Curé, et al.
Revue Des Maladies Respiratoires|June 1, 1997
[Role of nocturnal oximetry in screening for sleep apnea syndrome in pulmonary medicine. Study of 329 patients]L Lacassagne, A Didier, M Murris-Espin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1986
Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acidD Machover, E Goldschmidt, P Chollet, et al.
American Journal of Clinical Oncology|June 1, 1997
Adjuvant chemotherapy with doxorubicin-containing regimen for 326 stage II breast cancers: 15-year resultsJ P Ferrière, S Charrier, H Curé, et al.
Journal of Neuro-Oncology|April 1, 2006
Cystemustine in recurrent high grade gliomaX Durando, E Thivat, H Roché, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classesF-C Bidard, M-C Matthieu, P Chollet, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Neoadjuvant chemotherapy in 126 operable breast cancersE Bélembaogo, V Feillel, P Chollet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 2006
Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trialH Roché, P Kerbrat, J Bonneterre, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
European Journal of Cancer (Oxford, England : 1990)|March 8, 2006
A randomised phase II study of two different schedules of pegylated liposomal doxorubicin in metastatic breast cancer (EORTC-10993)R E Coleman, L Biganzoli, P Canney, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2004
Phase II study of OSI-211 (liposomal lurtotecan) in patients with metastatic or loco-regional recurrent squamous cell carcinoma of the head and neck. An EORTC New Drug Development Group studyF Duffaud, M Borner, P Chollet, et al.
Breast (Edinburgh, Scotland)|October 19, 2005
Neoadjuvant endocrine therapy in breast cancerC Abrial, M-A Mouret-Reynier, H Curé, et al.
Revue Des Maladies Respiratoires|June 1, 1997
[Role of nocturnal oximetry in screening for sleep apnea syndrome in pulmonary medicine. Study of 329 patients]L Lacassagne, A Didier, M Murris-Espin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1986
Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acidD Machover, E Goldschmidt, P Chollet, et al.
American Journal of Clinical Oncology|June 1, 1997
Adjuvant chemotherapy with doxorubicin-containing regimen for 326 stage II breast cancers: 15-year resultsJ P Ferrière, S Charrier, H Curé, et al.
Journal of Neuro-Oncology|April 1, 2006
Cystemustine in recurrent high grade gliomaX Durando, E Thivat, H Roché, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2008
p53 status and efficacy of primary anthracyclines/alkylating agent-based regimen according to breast cancer molecular classesF-C Bidard, M-C Matthieu, P Chollet, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Neoadjuvant chemotherapy in 126 operable breast cancersE Bélembaogo, V Feillel, P Chollet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 2006
Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trialH Roché, P Kerbrat, J Bonneterre, et al.
Pageof 14